Scientific Reports (Dec 2017)

Hypersensitivity of BRCA2 deficient cells to rosemary extract explained by weak PARP inhibitory activity

  • Cathy Su,
  • Jeffrey P. Gius,
  • Julia Van Steenberg,
  • Alexis H. Haskins,
  • Kazuki Heishima,
  • Chisato Omata,
  • Masahiro Iwayama,
  • Mami Murakami,
  • Takashi Mori,
  • Kohji Maruo,
  • Takamitsu A. Kato

DOI
https://doi.org/10.1038/s41598-017-16795-3
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Rosemary extract is used in food additives and traditional medicine and has been observed to contain anti-tumor activity. In this study, rosemary extract is hypothesized to induce synthetic lethality in BRCA2 deficient cells by PARP inhibition. Chinese hamster lung V79 cells and its mutant cell lines, V-C8 (BRCA2 deficient) and V-C8 with BRCA2 gene correction were used. Rosemary extract and its major constituent chemicals were tested for their cytotoxicity by colony formation assay in cells of different BRCA2 status. The latter chemicals were tested for inhibitory effect of poly (ADP-ribose) polymerase (PARP) activity in vitro and in vivo. Rosemary has shown selective cytotoxicity against V-C8 cells (IC50 17 µg/ml) compared to V79 cells (IC50 26 µg/ml). Among tested chemicals, gallic acid and carnosic acid showed selective cytotoxicity to V-C8 cells along with PARP inhibitory effects. Carnosol showed comparative PARP inhibitory effects at 100 µM compared to carnosic acid and gallic acid, but the selective cytotoxicity was not observed. In conclusion, we predict that within rosemary extract two specific constituent components; gallic acid and carnosic acid were the cause for the synthetic lethality.